Brian L. Hamilton
Keine laufenden Positionen mehr
Profil
Brian L.
Hamilton worked as a Senior Director of Clinical Research at Wyeth Research from 2001 to 2004.
He then worked as Vice President of Clinical and Regulatory Affairs at Merrimack Pharmaceuticals from 2004 to 2006.
In 2006, he became the Chief Medical Officer at BioVex, Inc. and later served as the Senior Vice President of Clinical Operations at Alaunos Therapeutics, Inc. He was also the Chief Medical Officer and Executive Vice President at Galena Biopharma, Inc. Additionally, he worked as the Chief Medical Officer and Senior Vice President at Soligenix, Inc. and as the Acting Vice President of Medical Affairs at Alaunos Therapeutics, Inc. Hamilton earned a doctorate degree from the University of Washington.
Ehemalige bekannte Positionen von Brian L. Hamilton
| Unternehmen | Position | Ende |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Technik-/Wissenschafts-/F&E-Leiter | 06.11.2014 |
| SOLIGENIX, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.11.2010 |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2009 |
| BioPharm Solutions, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2008 |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Technik-/Wissenschafts-/F&E-Leiter | 31.03.2007 |
Ausbildung von Brian L. Hamilton
| University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SOLIGENIX, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Commercial Services |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
| BioPharm Solutions, Inc. | |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
